About this trial
This new feasibility pilot study aims to refine the design and protocols for a larger trial that will investigate the potential benefits of early oral glucose tolerance test (OGTT) screening in a population traditionally defined as low-risk for development of gestational diabetes. The study will evaluate its potential effectiveness in reducing the risks of neonatal morbidity/mortality and obstetric complications. Additionally, a machine learning algorithm to predict gestational diabetes mellitus (GDM) risk based on routinely obtained clinical information at pregnancy booking, and minimally invasive methods, such as continuous glucose monitoring (CGM) and gingival crevicular fluid (GCF) sampling, are being explored to predict the risk of hyperglycaemia. This study aims to investigate the utility of early pregnancy screening to enable timely detection and management of early gestational diabetes development in a low-risk population, ultimately promoting better health outcomes for mothers and their babies.
Eligibility criteria
Qualifiers
Pregnant women aged 21-39 years at recruitment
Singleton pregnancy
Less than 16 weeks pregnant at recruitment
Intend to receive antenatal care and give birth at the National University Hospital
Disqualifiers
Known pre-existing type 1 or type 2 diabetes mellitus at recruitment
Taking systemic steroid medication or metformin
Participation in another intervention trial
Trial design
Treatments tested in this trial
- Early OGTT Results Revealed
Treatment groups
Sponsors and collaborators
National University Hospital, Singapore
Lead sponsor
National University of Singapore
Collaborator
Agency for Science, Technology and Research
Collaborator